Literature DB >> 8271282

Local recurrences following mastectomy: support for the concept of tumor dormancy.

R Demicheli1, M Terenziani, P Valagussa, A Moliterni, M Zambetti, G Bonadonna.   

Abstract

BACKGROUND: Local or regional recurrence of breast cancer occurs in 5%-30% of patients treated by Halsted radical or modified radical mastectomy. Lag time between treatment and recurrence varies widely, and it is not known whether the recurring tumor grows at a constant growth rate or at a more rapid rate after a period of tumor dormancy.
PURPOSE: This study was undertaken to discriminate between the above-mentioned hypotheses, i.e., determine whether a tumor that recurs after mastectomy grows at a constant rate or whether it grows rapidly following a period of tumor dormancy.
METHODS: A series of 122 patients with local recurrence as a first event after mastectomy for resectable breast cancer was evaluated. We measured the diameter of the recurring tumor (Dr) in each patient and calculated the diameter that the recurring tumor could have reached at the immediately preceding physical examination (Dpe), when no local relapse had yet been detected, by assuming an exponential growth during the treatment-free interval. For patients who had a calculated diameter Dpe that was large enough to have been detected at the previous examination, we assumed that a tumor 5 mm in diameter had been mistakenly missed, and the expected corresponding tumor diameter at the time of detection (Drc) was calculated. Finally, the minimum growth rate (mGR) consistent with the sequence "no detection-->recurrence of diameter Dr" was obtained by assuming an exponential growth from the tumor volume corresponding to a diameter 1 mm less than the diameter detection threshold.
RESULTS: A wide overlap between Dr and Dpe values was observed. Seventy-two (59%) of 122 Dpe values were larger than the minimum Dr; 18 (15%) were even larger than the median Dr value. The difference between expected and observed detection rates was highly significant (P < .0001). Furthermore, when treatment-free intervals were longer than 4 years, the difference between median Dr and median Dpe values failed to reach statistical significance. The Drc values were significantly lower than the related Dr values, while the mGR values were significantly higher than the corresponding growth rates (paired sample t test: P < .001).
CONCLUSION: This study provides evidence that the hypothesis of uninterrupted constant growth of locally recurring breast tumors should be rejected, as it implies a statistically significant departure from observed data. Our results suggest that a period of tumor dormancy followed by more rapid growth could provide an alternative and more reasonable description of tumor recurrence.

Entities:  

Mesh:

Year:  1994        PMID: 8271282     DOI: 10.1093/jnci/86.1.45

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  41 in total

Review 1.  Neoadjuvant chemoimmunotherapy in locally advanced breast cancer: a new avenue to be explored.

Authors:  Jan Buter; Herbert M Pinedo
Journal:  Curr Oncol Rep       Date:  2003-05       Impact factor: 5.075

2.  Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment.

Authors:  Stefano Indraccolo; Laura Stievano; Sonia Minuzzo; Valeria Tosello; Giovanni Esposito; Erich Piovan; Rita Zamarchi; Luigi Chieco-Bianchi; Alberto Amadori
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

Review 3.  Antiangiogenis restricted tumor dormancy.

Authors:  L Holmgren
Journal:  Cancer Metastasis Rev       Date:  1996-06       Impact factor: 9.264

4.  Breast and other cancer dormancy as a therapeutic endpoint: speculative recombinant T cell receptor ligand (RTL) adjuvant therapy worth considering?

Authors:  Tibor Bakács; Jitendra N Mehrishi
Journal:  BMC Cancer       Date:  2010-06-02       Impact factor: 4.430

Review 5.  Angiogenesis, metastasis, and endogenous inhibition.

Authors:  M Kirsch; G Schackert; P M Black
Journal:  J Neurooncol       Date:  2000 Oct-Nov       Impact factor: 4.130

6.  Dormant Wnt-initiated mammary cancer can participate in reconstituting functional mammary glands.

Authors:  Shelley A Gestl; Travis L Leonard; Jessica L Biddle; Michael T Debies; Edward J Gunther
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

Review 7.  Would cancer stem cells affect the future investment in stem cell therapy.

Authors:  Pranela Rameshwar
Journal:  World J Exp Med       Date:  2012-04-20

8.  Tumor dormancy due to failure of angiogenesis: role of the microenvironment.

Authors:  George N Naumov; Judah Folkman; Oddbjorn Straume
Journal:  Clin Exp Metastasis       Date:  2008-06-18       Impact factor: 5.150

9.  Bone recurrence after curative resection of gastric cancer.

Authors:  Jae Myung Park; Kyo Young Song; Joo Hyun O; Won Chul Kim; Myung-Gyu Choi; Cho Hyun Park
Journal:  Gastric Cancer       Date:  2012-09-08       Impact factor: 7.370

10.  New concepts in breast cancer emerge from analyzing clinical data using numerical algorithms.

Authors:  Michael Retsky
Journal:  Int J Environ Res Public Health       Date:  2009-01-20       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.